Rani Therapeutics this week touted the results of a first-in-human feasibility trial for its swallowable robotic pill, the RaniPill.
Rani has developed a capsule that delivers an intestinal injection of medicine without exposing the drugs to digestive enzymes.
Get the full story at our sister site, Drug Delivery Business News.